期刊文献+

TRAILmRNA与胃癌凋亡关系的研究 被引量:1

Relationship Between TRAILmRNA and Gastric Carcinoma Apoptosis
下载PDF
导出
摘要 目的检测肿瘤坏死因子相关凋亡诱导配体(TRAIL)mRNA在胃癌中的表达及其与凋亡的关系。方法利用原位杂交技术检测67例胃腺癌及对应的正常胃黏膜中TRAILmRNA的表达,同时利用原位末端标记技术(TUNEL)检测癌组织中的凋亡指数(AI),并分析它们之间的关系。结果①TRAILmRNA在正常胃黏膜中阳性表达率为95.52%,高于癌组织中的阳性表达率52.24%(P<0.05);②胃癌组织中细胞凋亡指数为1.85±0.66;③TRAILmRNA阳性组与阴性组中凋亡指数分别为3.06±0.45、1.21±0.13,两组间存在着显著性差异(P<0.05);④TRAILmRNA与胃癌组织中的患者的年龄、性别、肿瘤直径、部位、大体分型、浸润深度及有无淋巴结转移无明显的关系(P>0.05);与肿瘤的分化程度有关,分化程度越低,TRAIL的表达率越低(P<0.05)。结论TRAIL可能在胃癌凋亡过程中起重要作用。 Objective To detect the expression of TNF related apoptosis inducing ligand (TRAIL)mRNA in gastric carcinoma and the relationship of apoptosis.Methods Using in situ hybrization technology to detect the expression of TRAIL in 67 cases of gastric carcinoma and normal mucosa,at the same time to detect the apoptosis index(AI)in cancer tissues using TUNEL technology.Results ①The positive rate of TRAIL in normal mucosa(95.52%) was higher than it in cancer tissues (52.24%)(P<0.05).②The AI was 1.85±0.66 in gastric carcinoma tissues.③The AI between the TRAILmRNA positive group was (3.06±0.45) and negtive group was (1.21±0.13).The difference was clear(P<0.05).④There was no obvious relationship among TRAIL mRNA and tumors diameter,site,gross classification,invasion depth,lymphnodes metastasis and the patients' age and sex(P>0.05),and there was no significant relationship with tumour differentiation. The expression of TRAIL mRNA was lower accompany with the differentiation degree (P<0.05).Conclusion TRAIL may play an important role in the gastric cancer apoptosis procession.
出处 《河南职工医学院学报》 2005年第2期65-67,共3页 Journal of Henan Medical College For Staff and Workers
基金 河南省科技攻关基金资助项目(0011701219)
  • 相关文献

参考文献10

  • 1Wiley SR, Schooley K, Smolak P J, et al. Zdentification and characterization of a new member of the TNF family that induces apoptosis [J]. Immunity, 1995, 3: 673 ~ 682
  • 2Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligang in transformed cells of the T and B Lymphocyte lineage[J]. Eur J Immunol, 1998, 28:973 ~ 982
  • 3Jeremias I, Herr I, Boehler T, et al. TRAIL/Apo-2-1ig-and-induc-ed apoptosis in human T cells[J]. Eur J Immunol, 1998, 28:143 ~ 152
  • 4Phillip TA, Ni J, Pan G, et al. TRAIL (Apo-IL) and TRAIL receptors in human placentas: implications for immune pririlege [ J]. J Immunol, 1999,162:6 053 ~6 059
  • 5Walczak H, Degli-Esposti M A, Johnson RS, et al. TRAIL-Rz:a novel apoptosis mediating receptor for TRAIL [ J ]. EMBO J, 1997, 16(17):5 386~5 397
  • 6Naka T, Sugamura K, Hylander BL, et al. Effect sofiumorne crosisi factor related apoptosis inducing ligand lone and incom binatients' colontumors grown in SCID mice [ J ]. Cancer Res, 2002, 62 (20):5 800 ~ 5 806
  • 7Walczak H, Miller RE, Ariai LK, et al. Tumonicidal activity of tumor necrosis inducing ligand in vivo[J]. Nat Med, 1995,5:157 ~ 463
  • 8Ashkenazi A, Pal RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand [ J]. J Ciin Invest, 1999,104: 155 ~162
  • 9Wajant H,Pfizenmaier K, Scheurich P. TNF related apoptosis in ducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy[J]. Apoptosis, 2002, 7(5) :449 ~ 459
  • 10Cueiloo M, Ettenberg SA, Nau MM, et al. Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in themoresistant orarian cancer-cells[J]. Cynecol Oncol,2001,81(3) :380 ~ 390

同被引文献25

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部